open access

Vol 20, No 6 (2015)
Special Issue Papers
Published online: 2015-11-01
Submitted: 2014-06-20
Get Citation

Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve

Po-Ming Wang, Na-Na Chung, Wei-Chung Hsu, Feng-Ling Chang, Chin-Jyh Jang, Marta Scorsetti
DOI: 10.1016/j.rpor.2015.03.005
·
Rep Pract Oncol Radiother 2015;20(6):417-424.

open access

Vol 20, No 6 (2015)
Special Issue Papers
Published online: 2015-11-01
Submitted: 2014-06-20

Abstract

Aim

To discuss current dosage for stereotactic body radiation therapy (SBRT) in hepatocellular carcinoma (HCC) patients and suggest alternative treatment strategies according to liver segmentation as defined by the Couinaud classification.

Background

SBRT is a safe and effective alternative treatment for HCC patients who are unable to undergo liver ablation/resection. However, the SBRT fractionation schemes and treatment planning strategies are not well established.

Materials and methods

In this article, the latest developments and key findings from research studies exploring the efficacy of SBRT fractionation schemes for treatment of HCC are reviewed. Patients’ characteristics, fractionation schemes, treatment outcomes and toxicities were compiled. Special attention was focused on SBRT fractionation approaches that take into consideration liver segmentation according to the Couinaud classification and functional hepatic reserve based on Child–Pugh (CP) liver cirrhosis classification.

Results

The most common SBRT fractionation schemes for HCC were 3[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]10–20[[ce:hsp sp="0.25"/]]Gy, 4–6[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]8–10[[ce:hsp sp="0.25"/]]Gy, and 10[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]5–5.5[[ce:hsp sp="0.25"/]]Gy. Based on previous SBRT studies, and in consideration of tumor size and CP classification, we proposed 3[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]15–25[[ce:hsp sp="0.25"/]]Gy for patients with tumor size <3[[ce:hsp sp="0.25"/]]cm and adequate liver reserve (CP-A score 5), 5[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]10–12[[ce:hsp sp="0.25"/]]Gy for patients with tumor sizes between 3 and 5[[ce:hsp sp="0.25"/]]cm or inadequate liver reserve (CP-A score 6), and 10[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]5–5.5[[ce:hsp sp="0.25"/]]Gy for patients with tumor size >5[[ce:hsp sp="0.25"/]]cm or CP-B score.

Conclusions

Treatment schemes in SBRT for HCC vary according to liver segmentation and functional hepatic reserve. Further prospective studies may be necessary to identify the optimal dose of SBRT for HCC.

Abstract

Aim

To discuss current dosage for stereotactic body radiation therapy (SBRT) in hepatocellular carcinoma (HCC) patients and suggest alternative treatment strategies according to liver segmentation as defined by the Couinaud classification.

Background

SBRT is a safe and effective alternative treatment for HCC patients who are unable to undergo liver ablation/resection. However, the SBRT fractionation schemes and treatment planning strategies are not well established.

Materials and methods

In this article, the latest developments and key findings from research studies exploring the efficacy of SBRT fractionation schemes for treatment of HCC are reviewed. Patients’ characteristics, fractionation schemes, treatment outcomes and toxicities were compiled. Special attention was focused on SBRT fractionation approaches that take into consideration liver segmentation according to the Couinaud classification and functional hepatic reserve based on Child–Pugh (CP) liver cirrhosis classification.

Results

The most common SBRT fractionation schemes for HCC were 3[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]10–20[[ce:hsp sp="0.25"/]]Gy, 4–6[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]8–10[[ce:hsp sp="0.25"/]]Gy, and 10[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]5–5.5[[ce:hsp sp="0.25"/]]Gy. Based on previous SBRT studies, and in consideration of tumor size and CP classification, we proposed 3[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]15–25[[ce:hsp sp="0.25"/]]Gy for patients with tumor size <3[[ce:hsp sp="0.25"/]]cm and adequate liver reserve (CP-A score 5), 5[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]10–12[[ce:hsp sp="0.25"/]]Gy for patients with tumor sizes between 3 and 5[[ce:hsp sp="0.25"/]]cm or inadequate liver reserve (CP-A score 6), and 10[[ce:hsp sp="0.25"/]]×[[ce:hsp sp="0.25"/]]5–5.5[[ce:hsp sp="0.25"/]]Gy for patients with tumor size >5[[ce:hsp sp="0.25"/]]cm or CP-B score.

Conclusions

Treatment schemes in SBRT for HCC vary according to liver segmentation and functional hepatic reserve. Further prospective studies may be necessary to identify the optimal dose of SBRT for HCC.

Get Citation

Keywords

Hepatitis B virus; Hepatocellular carcinoma; Segment; Stereotactic body radiation therapy

About this article
Title

Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 20, No 6 (2015)

Pages

417-424

Published online

2015-11-01

DOI

10.1016/j.rpor.2015.03.005

Bibliographic record

Rep Pract Oncol Radiother 2015;20(6):417-424.

Keywords

Hepatitis B virus
Hepatocellular carcinoma
Segment
Stereotactic body radiation therapy

Authors

Po-Ming Wang
Na-Na Chung
Wei-Chung Hsu
Feng-Ling Chang
Chin-Jyh Jang
Marta Scorsetti

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl